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Abstract
Purpose The aim of this study is to report the efficacy of long
subcutaneous tunnelling of external ventricular drains in re-
ducing rates of infection and catheter displacement in a pae-
diatric population.
Methods In children requiring external ventricular drainage, a
long-tunnelled drain was placed and managed according to a
locallyagreedguideline.Endpoints werenovel CSFinfection
incurredduringthetimeofdrainageandre-operationtore-site
displaced catheters. Data were compared to other published
series.
Results One hundred eighty-one long-tunnelled external ven-
tricular drains (LTEVDs) were inserted. The mean age was
6.6 years (range 0–15.5 years). Reasons for insertion included
intraventricular haemorrhage (47 %), infection (27 %),
tumour-related hydrocephalus (7.2 %), as a temporising mea-
sure(17%)andtrauma(2.2%).Theoverallnewinfectionrate
for LTEVD was 2.76 %. If the 48 cases where LTEVDs were
inserted to treat an existing infection are excluded, the infec-
tion rate was 3.8 % (5/133). The mean duration of insertion
was 10 days (range 0–42 days). Four LTEVDs (2.2 %) were
inadvertently dislodged, requiring reinsertion. Thirteen pa-
tients required removal of EVD alone.
There was a significant difference (p<0.05) when compar-
ing our infection rate to 14 publications of infection rates in
short-tunnelledEVDs;however,therewasnodifferencewhen
comparing our data to three publications using LTEVDs.
Conclusion The use of an antibiotic-impregnated LTEVD,
managed according to a predefined guideline, is associated
with significantly reduced infection and displacement rates
when compared with contemporary series. It is suggested that
this reduction is of both clinical and economic benefits.
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Introduction
Insertion of external ventricular drains (EVDs) is one of the
most common neurosurgical procedures performed in neuro-
surgery today, with over 20,000 EVDs inserted annually in the
USA alone [1]. The most widely practised surgical technique
for insertion of EVDs involves the insertion of a ventricular
catheter into the ventricle with tunnelling of the distal end a
short distance away from the incision, a short-tunnelled EVD.
The complication rate from short-tunnelled EVDs is high
and includes infection, CSF leak, blockage, misplacement of
the ventricular catheter at the time of surgery and the inadver-
tentmigration of the ventricularcatheter followingsurgery [2].
The overall complication rate ranges from 3.4 to 32.2 % [2–8].
The presumed mechanism of infection is bacterial entry at
the exit site on the skin with subsequent ascending colonisa-
tion of the catheter. There are data suggesting that increasing
the distance from the EVD exit site to the burr hole reduces
infection [9–11].
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tunnelled EVD (LTEVD) would reduce the rate of novel
infection and, since LTEVDs require the incorporation of a
reservoir, would also reduce the rate of inadvertent migration
of the catheter out of the ventricle.
We have defined a LTEVD as a ventricular access device
comprising a ventricular catheter, a reservoir and a distal cath-
eter that is externalised at the level of the abdomen or anterior
chest wall. This paper is a retrospective audit of LTEVD
insertions at a single paediatric neurosurgical institution, spe-
cifically addressing infection and mechanical complications.
Methods
A retrospective review was conducted in all the patients who
had a LTEVD inserted from 2 January 2008 to 9 March 2012.
The policy of the neurosurgical department throughout the
course of this study was to insert all EVDs in the operating
theatre.
Protocol
A local guideline for insertionofLTEVDswasinplace for the
duration of this study. This comprised antibiotic prophylaxis
(flucloxacillin and amikacin) at induction of anaesthesia and
for a further period of 24 h, clipping of hair at least 2 cm away
from the wound and preparation of the field with povidone
iodine solution and/or chlorhexidine (0.5 % in 70 % alcohol).
Bactiseal™ antibiotic-impregnated ventricular and perito-
neal catheters were connected to a Miethke™ ventricular
access device. Subcutaneous tunnelling was performed from
the cranial wound to the chest wall or abdomen, allowing the
distal catheter to be passed. A purse-string suture was applied
to the exit site and covered with a waterproof dressing. The
peritoneal catheter was not cut, allowing a long length of
catheter to extend beyond the exit site.
Post-operatively, surgical and nursing staff followed the
external ventricular drain clinical guideline of Great Ormond
Street Hospital. Further details can be obtained from the lead
author. Drain management involved hourly checks of the
amount and colour of CSF drained, exit site condition and
the patients’ neurological condition. Redness, inflammation,
oozing of blood and CSF leakage at the exit site were all
documented. The post-operative dressing was changed at
24 h using 2 % chlorhexidine Clinell™ wipes to clean the
site.Followingthis,thedressingwaschangedweeklyorwhen
soiled.
Routine sampling of CSF from an EVD was not advocated
unless there was a specific clinical indication for fear of
introducing contamination into the sterile closed circuit. Pa-
tients presenting with shunt infection or de novo ventriculitis
requiringEVDinsertionhadCSFsamplingdaily.Forallother
cases, CSF sampling was performed on the day prior to
removal of the EVD or as part of a septic screen should the
child demonstrate clinical evidence of infection. All CSF
samples were sent to the on-site microbiology department
and processed immediately. A cell count was made up of the
neat CSF and a gram stain performed on the spun deposit, for
a differential white cell count and for the presence of organ-
isms. Primary culture of the spun deposit was performed on
bloodandchocolateagarincubatedfor40–48hat35–37°Cin
5–10 % CO2, MacConkey agarincubated for 18–24 h in air at
37 °C, Sabouraud agar incubated for 5 days in air at 35–37 °C
and blood agar incubated anaerobically for 5 days. Additional
enrichment was performed by inoculation of brain-heart infu-
sion for overnight enrichment at 35–37 °C followed by sub-
culture on blood and chocolate incubated for 18–24 h.
EVD catheter tips were cultured by rolling the terminal
5 cm across a blood agar plate and incubating at 35–37 °C for
18–24 h.
Data collection
In this study, a LTEVD infection was defined as a novel
bacterial growth or detection in the CSF and/or LTEVD
catheter that had arisen during the period of the LTEVD being
in situ and that resulted in a change in treatment (antibiotic
therapy and/or change of EVD). When assessing suspected
cases of LTEVD infection, systemic factors, white cell count
in the CSF, bacterial growth on culture from CSF/LTEVD
catheter samples and antibiotic treatment were all considered
before coming to a conclusion as to whether a LTEVD infec-
tion was present. LTEVD CSF infection was considered to
have occurred if there was growth on primary culture, growth
on subculture only and organisms were seen, growth in re-
peated samples on subculture when no organisms had been
seen or where organisms were seen on repeated gram stain
without growth. Growth from the tip without growth in the
CSFwasnotautomaticallygradedasaLTEVDCSFinfection.
Each case was managed on an individual basis. The lead
microbiology consultant for neurosurgery and the neurosur-
geon took the final decision as to whether the LTEVD had
been infected during the management of the case and that
decision has been used in this review.
The following data were retrieved from the departmental
operative database, operating theatre log and clinical record.
The total number of LTEVD procedures performed during
the study period, the number of LTEVD infections, the dura-
tion of insertion and the rate of inadvertent LTEVD dislodge-
ment were recorded. LTEVDs require a further surgical pro-
cedure under general anaesthetic for removal. It was noted
whether the removal of the LTEVD was part of another
surgical procedure (such as insertion of ventriculoperitoneal
(VP) shunt) or whether the removal was performed in
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LTEVD insertion was also recorded.
Patients who required LTEVD insertion due to an existing
infection were excluded from the data set when considering
the final infection rate, due to possible treatment-induced
discrepancies when testing for novel LTEVD infection.
When reporting the extra procedures needed for LTEVD
removal, LTEVD insertions for the cohort with existing infec-
tion (n=48) were omitted, as these patients would have had a
subsequent procedure to reinsert a shunt in theatre, irrespec-
tive of the type of EVD inserted.
A 2×2 Fisher’s exact test and Student’s t test were used for
assessingasignificantdifferencebetweenthecategoricaldata.
Results
One hundred seventy-seven patients had 181 LTEVDs placed
between 2 January 2008 and 9 March 2012. The mean age of
the patients was 6.6 years with a range of 0–15.5 years. Of the
181 procedures, 85 were inserted for intraventricular haemor-
rhage (47 %), 48 for infection (27 %), 13 for tumour-related
hydrocephalus (7.2 %), 31 as a temporising measure (17 %)
(where an EVD was inserted as an emergency measure and a
definitive CSF diversion was performed subsequently) and 4
for trauma (2.2 %).
Of the 133 patients with no existing infection, microbiolo-
gyanalysisidentifiedfivecases ofnovel LTEVDinfection,an
infection rate of 3.8 %. No LTEVD infections were identified
inthe cohort(n=48) thatrequireda LTEVDdue toanexisting
infection. Out of the total 181 procedures, five novel cases of
LTEVD infection were identified, an infection rate of 2.76 %.
Three other bacterial growths were recorded but were ex-
plained by sample contamination (two cases) and existing
surgical site infection (one case).
As can be seen in Table 1, there was no obvious trend for
infection in younger or older patients, with LTEVDs from a
widerange ofage groupsbeinginfected.Whencomparingthe
ages of the infected and non-infected groups, statistical anal-
ysis showed no evidence for age as a risk factor for LTEVD
infections(p=0.8967).FourofthefiveinfectedLTEVDswere
inserted for longer than the median duration of insertion;
however, there was no significant difference in LTEVD inser-
tion duration between the infected (n=5) and non-infected
(n=128) groups (p=0.1881). One of the infected cases was
inserted immediately after an endoscopic procedure. Four out
of the five infected LTEVD cases were caused by coagulase-
negative staphylococci (CONS).
The mean duration of LTEVD insertion was 11.2 days
(range 0 to 42 days and a median of 10 days, interquartile
range of 19 days).
Four out of 181 (2.2 %) of the LTEVD procedures carried
out during this time inadvertently dislodged, requiring an
extra procedure to reinsert the EVD. No patients required
EVDrevisionduetoblockage.Thirteenextraprocedureswere
carried out in theatre, specifically to remove the EVD, affect-
ing 13/133 (9.8 %) of our patients (excluding the 48 LTEVDs
inserted due to existing infection, as these would have an
inevitable subsequent procedure to reinsert a non-infected
shunt), where as the remainder of the removals were carried
out during a subsequent procedure the patient required; thus,
noextraprocedureswereneededtoremovethe EVD for these
patients. The total number of extra operations required in this
LTEVD cohort was thus 17 (9.4 %).
Discussion
A major complication of EVD insertion is CSF infection [2],
posing a significant risk to patients as well as placing an
additional burden on hospital resources. A range of infection
rates from short-tunnelled EVDs has been reported, from 3.4
to 32.2 % [2–8, 12–20]. The data for infection rates of short-
tunnelledEVDsare summarisedinFig.1.T h i ss t u d y ,u t i l i s i n g
LTEVD, reports a lower EVD infection rate when compared
with previously published literature.
EVD infections: the risk factors
Numerous studies have attempted to identify factors contrib-
uting to EVD-related infection. CSF leakage particularly near
the catheter exit site [21, 22], duration of EVD insertion [3,
12], EVD reinsertion [23], presence [24] or absence [25]o f
prophylactic antibiotics and CSF sampling [5] have all been
suggested as significant contributing factors towards the onset
of EVD-related infection. Other factors such as breaches of
the closed system [12]andsurgicalprotocolviolation[22]an d
regular catheter change [26] have also been investigated.
Comparing existing series is fraught with difficulty due to
thevaryingagegroupsstudied(adultandpaediatric),differing
underlying aetiology and lack of standardised protocols for
the insertion and management of EVDs. Currently, therefore,
there islittleagreement about the relativesignificanceofthese
contributing factors towards CSF infection in EVD patients.
What seems clear is that EVD infection is unacceptably high
in most reported series. This exclusively paediatric study of
long-tunnelled EVD incorporating a predefined guideline for
perioperative EVDmanagementhas revealedaninfection rate
of3.8%,aratesubstantiallylessthanthatpreviouslyreported.
The evidence for tunnelling in reducing EVD infection
CSF leakage, either at the cranial site or the EVD exit site, is
strongly correlated with infection risk. By increasing the
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CSF flow around the outside of the catheter will be greater,
thus reducing CSF leakage. Clearly, the distance that bacteria
have to migrate in order to colonise the CSF compartment is
also greater. Omar and Haspani found that tunnelling only as
far as 5 cm from the burr hole was sufficient to reduce the
infection rate from 62.9 to 11.5 % [9]. For postero-parietal or
parieto-occipital burr holes in children, the options for local
tunnelling are limited. We avoid exit sites in the region of the
neck as this is a mobile area with multiple skin creases.
Furthermore, wounds here are difficult to dress, are cosmeti-
cally unsatisfactory and may lie along the course of a subse-
quent shunt. Thus, we advocate tunnelling to the anterior
abdominal wall or, less commonly, the anterior chest wall
(well away from the nipple or breast bud), resulting in a
tunnelling distance of at least 20 cm.
The results presented inthispaper demonstrate comparable
results to the other two studies [27, 28] that have investigated
the effectiveness of LTEVDs. In the study by Khanna et al., a
0 % infection rate was achieved for the first 16 days after
LTEVD insertion and an overall infection rate of 4 %, in 100
adult and paediatric patients [27]. It was concluded that
LTEVDs had a low rate ofinfection and could remaininplace
f o ru pt o4 0d a y s .Am o r er e c e n ts t u d y[ 28], using a non-
antibiotic-impregnated LTEVD, in 114 adult and paediatric
patients requiring more than 7 days drainage, found the
Table 1 LTEVDinfectionsinthisseries:anoverviewdescribingtheorganismfoundintheCSF,theageatLTEVDinsertion,thedurationofinsertionof
the LTEVD and the reason for insertion
Data set number Organism on culture Age at insertion Duration of insertion
(days)
Reason for insertion
145 Coagulase-negative staphylococcus 5 years and 11 months 7 A temporising measure
(post endoscopic procedure)
169 Gram-positive cocci 9 months 28 Intraventricular haemorrhage
51 Coagulase-negative staphylococcus 15 years and 0 month 23 Intraventricular haemorrhage
88 Coagulase-negative staphylococcus 2 days 21 Temporising measure
(spinal dysraphism)
79 Coagulase-negative staphylococcus 15 years and 4 months 12 Intraventricular haemorrhage
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Fig.1 A comparison ofEVD infectionrates across previous series,usingeither a subcutaneouslong-tunnelled EVDorashort/non-tunnelledprocedure
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the infection rate of standard short-tunnelled EVDs. Notably,
LTEVDS were capable of remaining in place for long periods
of time (up to 60 days, with a mean duration of 20 days) and
no additional morbidity was associated with the LTEVD
procedure.
Both of these studies indicate promise of the LTEVD
technique though without conclusive evidence of their effec-
tiveness in the paediatric population.
Further strengthening the LTEVD argument: experience
from this single-centre study
OurstudydemonstratedaLTEVDinfectionrateof3.8%(five
out of 133), which, as demonstrated by Fig. 1, compares
favourably with previously published data on non-LTEVD
series. A review of EVD infection [2], using data from 23
studies, comprising 5,733 EVD procedures in both adults and
children, reported an infection rate of 8.8 %. Figure 1 com-
pares the infection rates in 15 publications [2, 3, 8, 9, 11, 19,
20,23, 29–35] usingshort-tunnelled EVDs and3publications
using LTEVDs [27–29] with our series. A statistically signif-
icant difference (p=<0.05) was found in the EVD-related
infection rate between our study and 14 of the studies using
the short-tunnelled procedure. Furthermore, there was no sig-
nificant difference in the infection rates when comparing our
study to the other three published studies using a long subcu-
taneous tunnel, suggesting that tunnelling seems to be a major
contributing factor when considering EVD infection.
The infection rate reported does not include the 48 cases
that required a LTEVD insertion for an existing infection as
these patients may have been on active treatment for existing
infection, which may affect the ability to detect a novel infec-
tion. Infection is a well-recognised complication of EVD
insertion in patients with clean CSF before insertion. Howev-
er, there is also a rate of novel infection, with new organisms,
inthegroupwheretheEVDisplacedasapartofthetreatment
for infection. There were no reported novel EVD infections in
this group with an existing infection (n=48). Therefore, the
total infection rate, including this group that require a LTEVD
for infection, is 2.76 % (five out of 181).
Four out of 181 (2.2 %) LTEVDs in this study were
inadvertently dislodged and required a separate procedure to
reinserttheEVD.DataontherateofdisplacementofEVDare
sparse. In another study, using short-tunnelled EVD, a dis-
lodgement rate of two out of 51 (8.1 %) was reported [11].
This would imply that the combination of a reservoir and
LTEVD affords some protection against this complication.
The average duration of insertion was 11.2 days, with one
LTEVD remaining in place for 42 days. Our data and the data
oftheotherLTEVDstudies[27–29]suggestthatLTEVDscan
safely remain in place for long periods of time without the
attendantrisksofinfectionanddislodgement.Itwasnotedthat
fourofthefiveinfectedLTEVDswereinsertedforlongerthan
the median duration of insertion; however, a statistical com-
parison found no significant difference in the ages of the two
groups. Duration of EVD insertion has been shown to be a
significantriskfactorwhenusingshort-tunnelledEVDs[2,3],
further strengthening the argument for a LTEVD protocol.
Additionally, one of the infected cases was inserted imme-
diately after an endoscopic procedure, suggesting that this
may have been a contributory factor to the LTEVD infection,
which would concur with the previous literature where intra-
operative endoscope use was considered to be an additional
risk factor when considering shunt infection rates in the pae-
diatric population [36].
The use of a LTEVD incorporating a reservoir will inevi-
tably result in an extra surgical procedure (to remove the
EVD) in some children. This study reported an extra proce-
dure rate of 9.4 %. We would argue that the benefits of the
long tunnel in terms of reducing infection rate and inadvertent
dislodgement outweigh this inconvenience.
Antibiotic-impregnated catheters: their importance
in reducing EVD infections
The importance of using an antibiotic-impregnated catheter
(AIC) to lower infection rates in this cohort must not be
underestimated. The Bactiseal™ catheters used for thiscohort
contained 0.15 % clindamycin and 0.054 % rifampicin. Sev-
eral recent studies have demonstrated the effectiveness of
using antibiotic-impregnated EVD catheters in both the adult
and paediatric population. A recent systematic review and
meta-analysis [37] identified several studies in both the adult
and paediatric populations where antibiotic impregnation of
the EVD catheter was beneficial in reducing EVD-related
infections.
A six-centre randomised controlled trial in the adult popu-
lation [38] has also shown a significant reduction in LTEVD
infections, from 9.4 to 1.3 % when using minocycline- and
rifampicin-impregnated catheters [38].Ina prospective versus
historical cohort study of 91 paediatric patients, Tamburrini
et al. [39] reported a significant reduction in EVD infection
rates, from 31.8 to 2.1 % when using AICs in paediatric
EVDs. In a further study, when AICs were inserted in a centre
already using prophylactic, systemic antibiotic treatment,
EVD infection rates were reduced from 23.5 to 4.3 % [40],
further strengthening the argument for AIC use in EVDs.
When considering the antibiotics impregnated into the
catheters, both minocycline/rifampin-impregnated ventricular
catheter andclindamycin/rifampin-impregnatedEVDcatheter
(used in this study) have been shown to be equally effective at
reducing EVD-related infections [41].
However, not all of the data suggest that AICs have a
beneficial impact in EVD insertion. A randomised controlled
trial of 184 patients from another centre [42]s h o w e dt h a t
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(1 %) compared to catheters without antibiotic impregnation
(3 %), and there was no significant difference of clinical
outcome at 6 months. A more recent randomised controlled
study also demonstrated similar findings in 348 adult patients,
where AICs used in EVDs did not contribute to a reduction in
infection rate; however, this could be attributed to a low
baseline rate of infection and so difficult to prove an AIC-
related reduction [43].
TheriskofafalsenegativeCSFculturewhendrawingCSF
fromanAICmustalsobeconsidered.Usinganinvitromodel,
an increased risk of false negative results of infected CSF has
been demonstrated [44]. Additionally, an increased rate of
infection has been noted in paediatric VP shunt patients with
prior EVD insertion using an AIC [45], the authors postulated
that prior use of an AIC increased the potential for resistant
organisms.
In summary, despite the possible risk offalse negative CSF
sampling and antibiotic resistance, there is a body of both
level I and level II evidences, supporting the conclusion that
AICs do reduce EVD infection rates.
TheroleofAICsusedasapartofthetreatmentprotocolfor
patients with pre-existing infection has been debated [46].
However, for the cohort requiring LTEVD insertion for pre-
existinginfectioninthisstudy(n=48),the AIC tubing was not
employed as a specific treatment for the infection, for which
appropriate intravenous and intraventricular antibiotics were
administered before LTEVD insertion. Therefore, despite the
licence for Bactiseal™ AIC catheters being for prevention of
infection only, it was departmental practice to use AICs for all
EVD insertions, whether infection was suspected at insertion
or not.
The relative contribution of AICs, a long subcutaneous
tunnel and a pre-defined protocol for perioperative manage-
ment of the EVD is difficult to elucidate in this study. There is
evidence from another study that a comprehensive EVD man-
agement protocol, similar to that implemented in this cohort,
waseffectiveinreducingEVD-relatedinfectionrates.Kubilay
et al. cited a reduction in infection rate from 1.06 to 0 % in
EVD procedures, over a 4-year period [47]. The effectiveness
of protocols in reducing shunt infection has also been well
demonstrated in the North American Shunt registry [48].
Implications and limitations
This low infection rate and low dislodgement rate shown for
EVDs in this study, using a LTEVD, an AIC and a perioper-
ative management protocol, represents a potential for both
clinical and economic benefits. Fewer EVD infections would
reduce the patient’s duration of hospital admission and reduce
the risk from further surgery required to replace an infected
EVD. A lower dislodgement rate is both safer for the patient
and cost-effective, as there is a reduced risk and cost brought
about by extra theatre time.
Our study does have some limitations. The multi-study
comparison (Fig. 1) does not take into account the different
operatingprotocolsandinfectiondefinitionsacrossthecentres
at which the procedures were carried out. As discussed, EVD-
related infection is a multi-factorial problem [49] and it would
be difficult to disregard all the compounding factors apart
from the tunnelling length and the use of AICs that may
influence the comparison with the other studies. This study
was also conducted in the paediatric population, and compar-
ingwithadultstudiesmaynotofferatruecomparison.Further
studies may wish to assess the cost-effectiveness of this pro-
cedure, specifically in relation to hospital stay and extra oper-
ating time.
Conclusion
Long-tunnelled EVDs, using an antibiotic-impregnated cath-
eter and managed according to an agreed perioperative man-
agement protocol, carry a lower infection rate and dislodge-
ment rate than the more widely used short-tunnelled proce-
dure. We believe that the reduced morbidity and costs associ-
ated with such a policy outweigh the disadvantage of requir-
ing an additional procedure for EVD removal.
Acknowledgments The authors thank Professor Hazel Inskip, MSc,
PhD, FFPH, Southampton University, for her assistance on statistical
analysis and Jody O’Connor, Clinical Nurse Specialist, Great Ormond
Street Hospital, for the development of the Great Ormond Street EVD
insertion protocol.
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. O’Neill BR, Velez DA, Braxton EE, Whiting D, Oh MY (2008) A
survey of ventriculostomy and intracranial pressure monitor place-
ment practices. Surg Neurol 70(3):268–273, Discussion 273
2. Lozier AP, Sciacca RR, Romangnoli MF, Connelly ES Jr (2002)
Ventriculostomy-related infection: a critical review of the literature.
Neurosurgery 51:170–182
3. Arabi Y, Memish ZA, Balkhy HH, Francis C, Ferayan A, Al
Shimemeri A, Almuneef MA (2005) Ventriculostomy-associated
infections: incidence and risk factors. Am J Infect Control 33(3):
137–143
1676 Childs Nerv Syst (2014) 30:1671–16784. AucoinPJ,KotilainenHR,GantzNM,DavidsonR,KelloggP,Stone
B (1986) Intracranial pressure monitors. Epidemiologic study of risk
factors and infections. Am J Med 80(3):369–376
5. Hader WJ, Steinbok P (2000) The value of routine cultures of the
cerebrospinal fluid in patients with external ventricular drains.
Neurosurgery 46(5):1149–1155
6. Öhrström JK, Skou JK, Ejlertsen T, Kosteljanetz M (1989) Infected
ventriculostomy: bacteriology and treatment. Acta Neurochir 100(1–
2):67–69
7. Pfisterer W, Muhlbauer M, Czech T, Reinprecht A (2003) Early
diagnosis of external ventricular drainage infection: results of a
prospective study. J Neurol Neurosurg Psychiatry 74:929–932
8. StenagerE,Gerner-SmidtP,Kock-JensenC(1986)Ventriculostomy-
related infections—an epidemiological study. ActaNeurochir(Wien)
83:20–23
9. Omar MA, Haspani MSM (2010) The risk factors of external ven-
tricular drainage-related infection at Hospital Kuala Lumpur: an
observational study. Malaysian J Med Sci 17(3):48–54
10. Sandalcioglu IE, Stolke D (2003) Failure of regular external ventric-
ular drain exchange to reduce CSF infection. J Neurol Neurosurg
Psychiatry 74:1598–1599
11. Berger A, Weninger M, Reinprecht A, Haschke N, Kohlhauser C,
Pollak A (2000) Long-term experience with subcutaneously
tunnelled external ventricular drainage in infants. Child’s Nerv Syst
16:103–110
12. Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward
JD, Narayan RK (1984) Ventriculostomy-related infections—ap r o -
spective epidemiologic study. N Engl J Med 310(9):553–559
13. Holloway KL, Barnes T, Choi S, Bullock R, Marshall LF, Eisenberg
HM, Jane JA, Ward JD, Young HF, Marmarou A (1996)
Ventriculostomy infections: the effect of monitoring duration and
catheter exchange in 584 patients. J Neurosurg 85(3):419–424
14. Chan KH, Mann KS (1988) Prolonged therapeutic external ventric-
ular drainage: a prospective study. Neurosurgery 23(4):436–438
15. Kanter RK, Weiner LB, Patti AM, Robson LK (1985) Infectious
complications and duration of intracranial pressure monitoring. Crit
Care Med 13(10):837–839
16. FriedmanWA,VriesJK(1980)Percutaneoustunnelventriculostomy.
Summary of 100 procedures. J Neurosurg 53(5):662–665
17. Paramore CG, Turner DA (1994) Relative risks of ventriculostomy
infection and morbidity. Acta Neurochir (Wien) 127(1–2):79–84
18. BogdahnU,LauW,HasselW,GunrebenG,MertensHG,Brawanski
A (1992) Continuous-pressure controlled, external ventricular drain-
age for treatment of acute hydrocephalus—evaluation of risk factors.
Neurosurgery 31(5):898–903, Discussion 903–4
19. Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJ (2008)
Risk factors for infections related to external ventricular drainage.
Acta Neurochir (Wien) 150(3):209–214, Discussion 214
20. MoonHJ,KimSD,LeeJB,LimDJ,ParkJY(2007)Clinicalanalysis
of external ventricular drainage related ventriculitis. J Korean
Neurosurg Soc 41(4):236–240
21. Korinek AM, Reina M, Boch AL, Rivera AO, De Bels D, Puybasset
L(2005) Preventionofexternalventriculardrain-relatedventriculitis.
Acta Neurochir (Wien) 147(1):39–45, discussion 45–6
22. Korinek AM (1997) Risk factors for neurosurgical site infections
after craniotomy: a prospective multicenter study of 2944 patients.
The French study group of neurosurgical infections, the SEHP, and
the C-CLIN Paris-Nord. Service Epidémiologie Hygiène et
Prévention. Neurosurgery 41(5):1073–1079, Discussion 1079–81
23. Lo CH, Spelman D, Bailey M, Cooper DJ, Rosenfeld JV, Brecknell
JE (2007) External ventricular drain infections are independent of
drain duration: an argument against elective revision. J Neurosurg
106(3):378–383
24. Sonabend AM, Korenfeld Y, Crisman C, Badjatia N, Mayer SA,
Connolly ES Jr (2011) Prevention of ventriculostomy-related infec-
tions with prophylactic antibiotics and antibiotic-coated external
ventricular drains: a systematic review. Neurosurgery 68(4):996–
1005, Jan 6
25. Alleyne CH Jr, Hassan M, Zabramski JM (2000) The efficacy and
cost of prophylactic and perioprocedural antibiotics in patients with
external ventricular drains. Neurosurgery 47(5):1124–1127,
Discussion 1127–9
26. Wong GKC, Poon WS, Wai S, Yu LM, Lyon D, Lam JMK (2002)
Failure of regular external ventricular drain exchange to reduce
cerebrospinal fluid infection: result of a randomised controlled trial.
J Neurol Neurosurg Psychiatry 73(6):759–761
27. Khanna RK, Rosenblum ML, Rock JP, Malik GM (1995) Prolonged
external ventricular drainage with percutaneous long-tunnel
ventriculostomies. J Neurosurg 83(5):791–794
28. Leung GK, Ng KB, Taw BB, Fan YW (2007) Extended subcutane-
ous tunnelling technique for external ventricular drainage. Br J
Neurosurg 21(4):359–364
29. Hur CW, Kim SH, Kim SW, Chang CH, Choi BY, Cho SH (2004)
External ventricular drainage system with long subcutaneous tunnel.
J Korean Neurosurg Soc 35(1):88–90
30. Muttaiyah S, Ritchie S, Upton A, Roberts S (2008) Clinical param-
eters do not predict infection in patients with external ventricular
drains:aretrospectiveobservationalstudyofdailycerebrospinalfluid
analysis. J Med Microbiol 57(2):207–209
31. Hayat A, Rodrigues D, Crawford P, Mendelow D (2009) External
ventriculardrains—canmorbiditybereduced.PakJNeurosci4(1):1–
3
32. Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent JL (2005)
Ventriculostomy-related infections in critically ill patients: a 6-year
experience. J Neurosurg 103(3):468–472
33. Schade RP, Schinkel J, Visser LG, Van Dijk JM, Voormolen JH,
Kuijper EJ (2005) Bacterial meningitis caused by the use of ventric-
ularorlumbarcerebrospinalfluidcatheters.JNeurosurg102(2):229–
234
34. Scheithauer S, Bürgel U, Bickenbach J, Häfner H, Haase G,
Waitschies B, Reinges MHT, Lemmen SW (2010) External ventric-
ular and lumbar drainage-associated meningoventriculitis: prospec-
tive analysis of time-dependent infection rates and risk factor analy-
sis. Infection 38(3):205–209
35. Camacho EF, Boszczowski I, Basso M, Jeng BCP, Freire MP,
Guimarães T, Teixeira MJ, Costa SF (2011) Infection rate and risk
factorsassociatedwithinfectionsrelatedtoexternalventriculardrain.
Infection 39(1):47–51
36. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ
(2003) Risk factors for pediatric ventriculoperitoneal shunt in-
fection and predictors of infectious pathogens. Clin Infect Dis
36(7):858–862
37. Thomas R, Lee S, Patole S, Rao S (2012) Antibiotic-impregnated
catheters for the prevention of CSF shunt infections: a systematic
review and meta-analysis. Br J Neurosurg 26(2):175–184
38. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J,
Robertson C, Hamilton AJ (2003) Efficacy of antimicrobial-
impregnated external ventricular drain catheters: a prospective, ran-
domized, controlled trial. J Neurosurg 98(4):725–730
39. Tamburrini G, Massimi L, Caldarelli M, Di Rocco C (2008)
Antibiotic impregnated external ventricular drainage and third
ventriculostomy in the management of hydrocephalus associated
with posterior cranial fossa tumours. Acta Neurochir 150(10):
1049–1056
40. Wright K, Young P, Brickman C, Sam T, Badjatia N, Pereira M,
Connolly ES, Yin MT (2013) Rates and determinants of
ventriculostomy-related infections during a hospital transition to use
of antibiotic-coated external ventricular drains. Neurosurg Focus
34(5):E12
41. Abla AA, Zabramski JM, Jahnke HK, Fusco D, Nakaji P (2011)
Comparison of two antibiotic-impregnated ventricular catheters: a
prospective sequential series trial. Neurosurgery 68(2):437–442
Childs Nerv Syst (2014) 30:1671–1678 167742. Wong GK, Ip M, Poon WS, Mak CW, Ng RY (2010) Antibiotics-
impregnated ventricular catheter versus systemic antibiotics for pre-
vention of nosocomial CSF and non-CSF infections: a prospective
randomised clinical trial. J Neurol Neurosurg Psychiatry 81(10):
1064–1067
43. Pople I, Poon W, Assaker R, Mathieu D, Iantosca M, Wang E,
Zhang LW, Leung G, Chumas P, Menei P, Beydon L, Hamilton
M, Kamaly I, Lewis S, Ning W, Megerian JT, McGirt MJ,
Murphy JA, Michael A, Meling T (2012) Comparison of infec-
tion rate with the use of antibiotic-impregnated vs standard
extraventricular drainage devices: a prospective, randomized
controlled trial. Neurosurgery 71(1):6–13
44. Stevens EA, Palavecino E, Sherertz RJ, Shihabi Z, Couture DE
(2010) Effects of antibiotic-impregnated external ventricular drains
on bacterial culture results: an in vitro analysis: laboratory investiga-
tion. J Neurosurg 113(1):86–92
45. Hayhurst C, Cooke R, Williams D, Kandasamy J, O’Brien DF,
Mallucci CL (2008) The impact of antibiotic-impregnated catheters
on shunt infection in children and neonates. Childs Nerv Syst 24(5):
557–562
46. Soleman J, Marbacher S, Fandino J, Fathi AR (2012) Is the use of
antibiotic-impregnated external ventricular drainage beneficial in the
management of iatrogenic ventriculitis? Acta Neurochir 154(1):161–
164
47. Kubilay Z, Amini S, Fauerbach LL, Archibald L, Friedman WA,
LayonAJ(2013)Decreasingventricularinfectionsthroughtheuseof
a ventriculostomy placement bundle: experience at a single institu-
tion: clinical article. J Neurosurg 118(3):514–520
48. Kestle JR, Riva-Cambrin J, Wellons JC III, Kulkarni AV, Whitehead
WE, Walker ML, Oakes J, Drake JM, Luerssen TG, Simon TD,
Holubkov R (2011) A standardized protocol to reduce cerebrospinal
fluid shunt infection: the hydrocephalus clinical research network
quality improvement initiative. J Neurosurg Pediatr 8(1):22
49. Babu MA, Patel R, Marsh WR, Wijdicks EF (2012) Strategies to
decrease the risk of ventricular catheter infections: a review of the
evidence. Neurocrit Care 16(1):194–202
1678 Childs Nerv Syst (2014) 30:1671–1678